dc.creatorCarlos, G.
dc.creatorUribe González, Pablo Francisco
dc.creatorFernández-Peñas, P.
dc.date.accessioned2020-01-14T01:06:52Z
dc.date.available2020-01-14T01:06:52Z
dc.date.created2020-01-14T01:06:52Z
dc.date.issued2013
dc.identifier0312-8008
dc.identifierhttps://repositorio.uc.cl/handle/11534/27447
dc.identifier10.18773/austprescr.2013.063
dc.description.abstractMany dermatological conditions will respond to a topical corticosteroid. The clinical outcome will depend on making a correct clinical diagnosis and applying the right molecule in the most appropriate vehicle for the correct duration. Topical corticosteroids are classified by their strength, but the same molecule will have different effects depending on the vehicle. The patient's age and the affected area of skin are other important factors. If used correctly the adverse effects of topical corticosteroids are usually minimal. Systemic effects can occur with high doses.
dc.rightsacceso abierto
dc.subjectAtrophy
dc.subjectCream
dc.subjectOintment
dc.subjectPregnancy
dc.subjectVehicle
dc.subjectBetamethasone dipropionate
dc.subjectBetamethasone valerate
dc.subjectClobetasol propionate
dc.subjectClobetasone
dc.subjectCorticosteroid
dc.subjectDesonide
dc.subjectDrug vehicle
dc.subjectEmulsifying agent
dc.subjectHydrocortisone
dc.subjectHydrocortisone acetate
dc.subjectMethylprednisolone aceponate
dc.subjectMometasone furoate
dc.subjectTriamcinolone acetonide
dc.subjectAcne
dc.subjectAdrenal cortex insufficiency
dc.subjectAge
dc.subjectArticle
dc.subjectClinical trial (topic)
dc.subjectDiabetes mellitus
dc.subjectDrug absorption
dc.subjectDrug classification
dc.subjectDrug efficacy
dc.subjectDrug indication
dc.subjectDrug penetration
dc.subjectDrug potency
dc.subjectDrug safety
dc.subjectDrug use
dc.subjectDrug withdrawal
dc.subjectGlaucoma
dc.subjectHuman
dc.subjectHyperglycemia
dc.subjectHypopigmentation
dc.subjectHypothalamus hypophysis adrenal system
dc.subjectLactation
dc.subjectLotion
dc.subjectPatient compliance
dc.subjectPerioral dermatitis
dc.subjectPrescription
dc.subjectRash
dc.subjectRosacea
dc.subjectSide effect
dc.subjectSkin atrophy
dc.subjectSkin disease
dc.subjectTachyphylaxis
dc.subjectTreatment duration
dc.subjectTreatment response
dc.subjectUnspecified side effect
dc.subjectVasoconstriction
dc.subjectWound healing impairment
dc.titleRational use of topical corticosteroids
dc.typeArtículo


Este ítem pertenece a la siguiente institución